ACRES and EXOCHAIN To Accelerate Clinical Research with LYNK BLOCKCHAIN Protocol
Posted January 17, 2018 by Mary Tobin
The Alliance for Clinical Research Excellence and Safety® signs Agreement with EXOCHAIN™ to Provide Blockchain Technology in Support of Patient and Physician Secure Identity in Clinical Trials.
EXOCHAIN CEO and co-founder, Bob Stewart: “Success… depends on trust, accessibility, and immutability of shared data and transparency. This is a perfect use case for EXOCHAIN’s LYNK utility token—enabling secure lifetime and transgenerational medical record sharing between providers and patients”
CAMBRIDGE, MASS. (PRWEB) JANUARY 17, 2018
The Alliance for Clinical Research Excellence and Safety (ACRES), announced today a 10-year exclusive agreement with EXOCHAIN CORP to provide blockchain protocols as infrastructure to verify the secure identity of patients and doctors participating in clinical trials and enhance all aspects of clinical research and practice.
ACRES is a global non-profit multi-stakeholder alliance with more than 140 strategic allies worldwide. Their shared mission is to build, implement and maintain an integrated, comprehensive global system for clinical research that is effective, innovative and ethical.
A significant challenge to this goal is securing the health data of patients participating in clinical trials, a necessary step for its utilization and sharing amongst researchers and healthcare providers. EXOCHAIN’s new blockchain protocol addresses this challenge.
As Greg Koski, ACRES President and co-founder noted, “Precision medicine and personalized medicine is the future, where evidence-driven practice is integrated with, and informed by, high-quality research. Done correctly, this approach requires enterprise-scale access to information from millions of patients in a manner that ensures secure identity and access management across locations and generations. Innovative application of blockchain technology, as ACRES is now doing with EXOCHAIN, provides the key to the success of this new paradigm.”
EXOCHAIN CEO and co-founder, Bob Stewart, who also serves as ACRES CTO and CISO, explains, “We are excited to work with the ACRES BlueCloud network to implement ACRES-guided standards for effectively designing and conducting clinical trials, standards which are designed to improve patient outcomes by delivering the right care, at the right time, and which require information derived from analyses of massive sets of shared data. Success of this approach depends on trust, accessibility, and immutability of shared data and transparency. This is a perfect use case for EXOCHAIN’s LYNK utility token—enabling secure lifetime and transgenerational medical record sharing between providers and patients and then, their progeny.”
To start, EXOCHAIN will integrate its new blockchain protocol to enable secure identity and access management for the BlueCloud.net collaborative networking platform that provides ACRES universal interface for interactions among all stakeholders in the clinical research and healthcare enterprise, currently with more than 1.3 million users.
The new LYNK token-based blockchain protocol developed by EXOCHAIN is also well suited to support many other secure transactions critical to the clinical research and healthcare environment, including adverse event reporting and adjudication, remote study monitoring and regulatory oversight, as well as other highly-regulated endeavors in which secure and trackable data-transactions are essential.
Koski added, “We at ACRES are both excited and grateful for all that Bob Stewart and EXOCHAIN bring to this partnership and vision, including a significant contribution from EXOCHAIN to ACRES upon execution of our partnership agreement”.
EXOCHAIN co-founder Major Dan Winschel, APA-C, a former Special Forces medic, who is currently a physician’s assistant for Veterans Affairs said, “EXOCHAIN believes in the vision and mission of ACRES, and we intend to support it as vigorously as we can. This is the beginning of a special relationship and we are proud to be part of the ACRES unique mission, especially in support of Task Force Dagger Foundation’s Operation Restore.”
Stewart will be announcing and presenting details of the new EXOCHAIN LYNK protocol and the ACRES partnership at the North American Bitcoin Conference in Miami, Jan 18-19, at the James L. Knight Center. Follow the events live via Twitter using hashtags #EXOCHAINLYNK #BTCMiami and #TNABC.
The Alliance for Clinical Research Excellence and Safety (ACRES), a non-profit alliance working in the public interest, brings together stakeholders spanning the clinical research ecosystem to build an open, integrated global system based in Accountable Research™. ACRES applies principles of systems and safety engineering, such as in transportation, communications and information technology.
About EXOCHAIN CORP
EXOCHAIN is leading identity, legal governance, risk management and regulatory compliance for blockchain platforms. EXOCHAIN is building a token-based blockchain ecosystem that medical providers (hospitals, research organizations, universities) can use to verify the secure identity of patients and doctors participating in clinical trials. With an easier, faster, immutable process to transport healthcare data, EXOCHAIN will help its customers contribute to clinical research, improve medical records and accelerate the discovery of cures. Please read our white paper at http://www.exochain.com.
DR. MARY F. TOBIN
Special Advisor to the President and Chief Executive Officer
Alliance for Clinical Research Excellence and Safety (ACRES)
Chief of Staff
(207) 536-5848 Ext. 110